Tudor Investment Corp
SGNT

Tudor Investment Corp’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Tudor Investment Corp’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11,664
Closed -$142K – 2107
2016
Q1 		$142K Sell
11,664
-14,165
-55% -$199K ﹤0.01% 1572
2015
Q4 		$411K Buy
+25,829
New +$407K 0.01% 1026
2015
Q3 		– Sell
-22,692
Closed -$552K – 1892
2015
Q2 		$552K Buy
22,692
+10,792
+91% +$259K 0.02% 719
2015
Q1 		$277K Sell
11,900
-15,000
-56% -$397K 0.01% 1098
2014
Q4 		$675K Buy
26,900
+14,200
+112% +$417K 0.02% 561
2014
Q3 		$395K Sell
12,700
-5,500
-30% -$149K 0.01% 822
2014
Q2 		$471K Buy
+18,200
New +$404K 0.02% 572

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Tudor Investment Corp's SGNT Position: Q2 2016 in Review

Tudor Investment Corp sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 11,664 shares — an estimated $142K sold.

Tudor Investment Corp first reported a position in SGNT in Q2 2014 and held it in 7 quarters. The position peaked at $675K in Q4 2014. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Tudor Investment Corp reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Tudor Investment Corp sold 11,664 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $142K.
  • Tudor Investment Corp first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 7 quarters.
  • Tudor Investment Corp's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $675K in Q4 2014.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Tudor Investment Corp's 13F filing for Q2 2016, filed 15 Aug 2016.